Minerva Neurosciences, INC. (NERV) — 8-K Filings

8-K Filings (11)

• 8-K Filing — Dec 22, 2025
• Minerva Neurosciences Reports Director/Officer Changes & Compensation — Nov 19, 2025 Risk: medium
  Minerva Neurosciences, Inc. filed an 8-K on November 19, 2025, reporting events as of November 14, 2025. The filing indicates a departure of directors or certai
• Minerva Neurosciences Files 8-K with Key Corporate Updates — Oct 22, 2025 Risk: medium
  Minerva Neurosciences, Inc. filed an 8-K on October 22, 2025, reporting on events as of October 21, 2025. The filing indicates entry into a material definitive
• Minerva Neurosciences Files 8-K — Mar 19, 2025 Risk: low
  Minerva Neurosciences, Inc. filed an 8-K on March 19, 2025, reporting an event that occurred on March 17, 2025. The filing is categorized under 'Other Events' a
• Sosei to Acquire Minerva Neurosciences for $1.5B — Jan 13, 2025 Risk: medium
  Minerva Neurosciences, Inc. announced on January 10, 2025, that it has entered into a definitive agreement to be acquired by Sosei Group Corporation for approxi
• Minerva Neurosciences Files 8-K on Shareholder Votes — Dec 5, 2024 Risk: low
  Minerva Neurosciences, Inc. filed an 8-K on December 5, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's
• Minerva Neurosciences Faces Delisting Concerns — Oct 11, 2024 Risk: high
  Minerva Neurosciences, Inc. filed an 8-K on October 11, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The co
• Minerva Neurosciences Files 8-K — Sep 16, 2024 Risk: medium
  Minerva Neurosciences, Inc. filed an 8-K on September 16, 2024, reporting an "Other Event" as of September 14, 2024. The filing does not contain specific detail
• Minerva Neurosciences Announces Board and Executive Changes — May 30, 2024 Risk: medium
  Minerva Neurosciences, Inc. announced on May 29, 2024, changes in its board of directors and executive compensation. Dr. Jonathan F. Miller has been appointed a
• Minerva Neurosciences Faces Nasdaq Delisting Warning — Apr 12, 2024 Risk: high
  Minerva Neurosciences, Inc. announced on April 10, 2024, that it received a notice from Nasdaq regarding its failure to meet the minimum bid price requirement f
• Minerva Neurosciences Files 8-K for Other Events & Exhibits — Feb 27, 2024 Risk: low
  Minerva Neurosciences, Inc. filed an 8-K on February 27, 2024, reporting an event that occurred on February 26, 2024. The filing indicates 'Other Events' and 'F

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX